PAX8 and uterine cancer: Clinically, positive immunohistochemical staining for PAX8 is widely used to diagnose primary renal cell tumors and mutations are also frequently seen in thyroid, ovarian, bladder, prostate, endometrial, cervical, and uterine cancers (29).